Position in SOLV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$11,980,777
-$209,427 QoQ
Shares Held
155,292
-16.8% QoQ
Ownership
0.091%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#85
of 875 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 82%
Shared 0%
None 18%
Common Shares in SOLV Over Time
Shares Held
Position Value (USD)
Position in Medical Instruments & Supplies
Healthcare · as of Jun 30, 2026ALLIANCEBERNSTEIN L.P. holds $2,276,784,258 across 32 Medical Instruments & Supplies names. SOLV ranks #12 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ISRG |
Intuitive Surgical Inc
|
3,632,766 | $1,444,678,382 | |
| 2 | MDLN |
Medline Inc.
|
4,199,970 | $165,646,816 | |
| 3 | NVST |
Envista Holdings Corp
|
5,213,644 | $137,379,519 | |
| 4 | RGEN |
Repligen Corp
|
795,282 | $108,508,276 | |
| 5 | RMD |
Resmed Inc
|
491,472 | $95,778,063 | |
| 6 | ATRC |
AtriCure, Inc.
|
2,768,365 | $77,458,852 | |
| 7 | BDX |
Becton Dickinson & Co
|
328,605 | $49,727,794 | |
| 8 | KMTS |
Kestra Medical Technologies, Ltd.
|
1,477,992 | $37,600,116 |
All Filings in SOLV
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,980,777 | 155,292 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $12,190,204 | 186,680 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $12,576,655 | 158,716 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $11,289,523 | 154,651 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $14,574,703 | 192,177 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $11,556,863 | 151,984 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $10,110,747 | 153,054 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $11,048,179 | 158,465 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $8,268,634 | 156,366 | Shares | Defined | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||